4//SEC Filing
Eisner Mark 4
Accession 0001209191-23-018063
CIK 0000921299other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 9:55 PM ET
Size
11.6 KB
Accession
0001209191-23-018063
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Eisner Mark
Incoming Chief Medical Officer
Transactions
- Sale
Common Stock
2023-03-10$20.20/sh−6,255$126,334→ 175,176 total - Sale
Common Stock
2023-03-08$21.16/sh−7,363$155,771→ 165,133 total - Award
Common Stock
2023-03-08+7,732→ 172,865 total - Award
Common Stock
2023-03-08+12,451→ 185,316 total - Sale
Common Stock
2023-03-10$20.20/sh−3,885$78,467→ 181,431 total
Footnotes (5)
- [F1]Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
- [F2]Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023.
- [F3]Represents the number of shares released for PSU TSR Grant vested on March 8, 2023.
- [F4]Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU Milestone previously reported in Table I.
- [F5]Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I.
Documents
Issuer
FIBROGEN INC
CIK 0000921299
Entity typeother
Related Parties
1- filerCIK 0001834161
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 9:55 PM ET
- Size
- 11.6 KB